Search
for
Sort by
Research 121–150 of 1000+
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Recent Advances in Genome-Editing Technology with CRISPR/Cas9 Variants and Stimuli-Responsive Targeting Approaches within Tumor Cells: A Future Perspective of Cancer Management
- Growth inhibition of mouse skin tumor by serine protease inhibitor ONO-3403.
- The Potential of Ultrasound Technology and Chemotherapy Carriers in Breast Cancer Treatment
- Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
- Monte Carlo simulation‐guided design for size‐tuned tumor spheroid formation in 3D printed microwells
- Case Report: Postmenopausal hyperandrogenism misled by adrenal incidentaloma: a rare case of androgen-secreting ovarian adult granulosa cell tumor and clinical implications
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Original synthetic monophenolic antioxidant with combined effect inhibits tumor growth in vivo
- Fractional erbium-doped yttrium aluminum garnet laser 2940 nm-assisted delivery of topical timolol solution for the treatment of histiocytoid hemangioma
- Abstract P5-09-21: Selective androgen receptor modulators (SARMs): Enobosarm as targeted therapy for the treatment of androgen receptor-positive breast cancer
- Patient experience with later line chemotherapy in four tumor types.
- Pathological Insights into the Limitations of Clinical and Dermoscopic Evaluations in Monitoring Sonidegib Treatment Response for Locally Advanced Basal Cell Carcinoma: A Real-World Study
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
- Novel small molecules downregulate CDK1 expression and inhibit Wnt/β-catenin signaling in cutaneous squamous cell carcinoma by targeting its distinct tumor-specific cellular landscape
- Poster Presentations
- Induction of ornithine decarboxylase in specific subpopulations of murine epidermal cells following multiple exposures to 12-<i>O</i>-tetradecanoylphorbol-13-acetate, mezerein and ethyl phenylpropriolate
- Expression of keratins K6 and K16 in regenerating mouse epidermis is less restricted by cell replication than the expression of K1 and K10.
- Tumor Angiogenesis and Anti-angiogenic Therapy
- [Hirsutism].
- Disruption of tubular Flcn expression as a mouse model for renal tumor induction
- ONKOLOGIA OKULISTYCZNA WCZORAJ I DZIŚ
- RTHP-40. EFFECT OF RIND-BASED DOSIMETRIC TECHNIQUES FOR SCALP DOSE REDUCTION IN BRAIN IRRADIATION
- Tracing the cellular origin of cancer
- Keratins and skin disease
- Diseases of the Canine Prostate Gland
- Increased Incidence of Telogen Effluvium Following Platelet-Rich Plasma Therapy in Patients with Elevated TNF-α Expression: A Prospective Cohort Study
- Hyperandrogénie féminine
- Corticotropin releasing factor-1 receptor antagonism associated with favorable outcomes of male reproductive health biochemical parameters